PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
about
Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitorsThe identification of specific methylation patterns across different cancersPARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expressionRegulation of Bone Morphogenetic Protein Signaling by ADP-ribosylation.The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.Anoikis and EMT: Lethal "Liaisons" during Cancer Progression.PARP Inhibitors in Prostate Cancer.High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer.Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases.Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.DNA-dependent protein kinase plays a central role in transformation of breast epithelial cells following alkylation damage.The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5.
P2860
Q26768267-CEFB65E6-036F-4201-AFBF-FC44499CE625Q35182046-7A1B2E8A-5B40-4D8F-994B-91D820BAC27BQ36020900-92D19E8C-9BC9-444D-8FA5-8BB18F3CCC32Q37066555-1332F9CE-D24F-43F7-84D2-75E29DF1897DQ37513919-3EC919A1-E597-4FBE-B7F7-EF13835BED3CQ38683171-EA0B3862-5B1F-46CA-A24C-EC08E269EFE6Q39028687-0BE7C98B-34F5-4D7B-B4D9-54280282C257Q39328164-53AC0DE2-D7D9-43AC-A199-D694A432A903Q40432109-8FF54D7C-45B5-43F5-BA47-3378352CE932Q45370081-C970DFA1-0154-419E-ACC0-AB357431B26DQ47257677-14095EFE-492E-4269-BFFD-C559C3004BE3Q47611805-DE68E110-3B87-4D4E-9CEC-42E22AA5694EQ47782486-4AD37C24-5F5C-4783-985D-C4B99AC80DF6Q51337382-38CE2B6C-E04D-471C-9EA9-809993C47C1A
P2860
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
@ast
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
@en
PARP-1 regulates epithelial-mesenchymal transition
@nl
type
label
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
@ast
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
@en
PARP-1 regulates epithelial-mesenchymal transition
@nl
prefLabel
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
@ast
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
@en
PARP-1 regulates epithelial-mesenchymal transition
@nl
P2093
P2860
P356
P1433
P1476
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
@en
P2093
Craig Horbinski
Emily A Matuszak
Natasha Kyprianou
Timothy Atkinson
P2860
P304
P356
10.1093/CARCIN/BGU183
P407
P577
2014-08-30T00:00:00Z